STBCi322-A

Registration Summary:

A P E C

SB-AD3c1, AD3c1, SBAD03-01, SFC-AD3-01

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	STBCi322-A
Cite as:	STBCi322-A (RRID:CVCL_ZX55)
Alternative name(s)	SB-AD3c1, AD3c1, SBAD03-01, SFC-AD3-01
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	13th April 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	StemBANCC (STBC)
Owner	University of Newcastle (UNEW)
Distributors	EBiSC
External Databases
Cellosaurus	CVCL_ZX55
Wikidata	Q102114949
General Information
Publications	Haenseler W et al. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response. Stem cell reports. 2017 Jun 6;8(6):1727-1742. Rauch C et al. Differentiation of human iPSCs into functional podocytes. PloS one. 2018;13(9):e0203869. Gupta SK et al. NKX6.1 induced pluripotent stem cell reporter lines for isolation and analysis of functionally relevant neuronal and pancreas populations. Stem cell research. 2018 May;29:220-231. Garcia-Reitboeck P et al. Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis. Cell reports. 2018 Aug 28;24(9):2300-2311. Xiang X et al. The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans. Molecular neurodegeneration. 2018 Sep 6;13(1):49. Volpato V et al. Reproducibility of Molecular Phenotypes after Long-Term Differentiation to Human iPSC-Derived Neurons: A Multi-Site Omics Study. Stem cell reports. 2018 Oct 9;11(4):897-911. Fang EF et al. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease. Nature neuroscience. 2019 Mar;22(3):401-412. Huijbregts L et al. Bromodomain and Extra Terminal Protein Inhibitors Promote Pancreatic Endocrine Cell Fate. Diabetes. 2019 Apr;68(4):761-773.
Subclones	STBCi322-A-1 STBCi322-A-2 STBCi322-A-3 STBCi322-A-4 STBCi322-A-5 STBCi322-A-6 STBCi322-A-7

hIPSC Derivation

General